BioCentury
ARTICLE | Clinical News

Gvax cancer vaccine: Approved a Phase I trial

August 15, 1994 7:00 AM UTC

Somatix Therapy Corp. ( SOMA), Alameda, Calif. Product: Gvax cancer vaccine Indication: Ex vivo gene therapy for prostate cancer, created from patients' cells cultured and engineered to make GM-CSF St...